🇺🇸 FDA
Patent

US 7326691

Compositions comprising amphotericin B, methods, and systems

granted A61KA61K31/7048A61K9/0075

Quick answer

US patent 7326691 (Compositions comprising amphotericin B, methods, and systems) held by Nektar Therapeutics expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/7048, A61K9/0075, A61K9/1611, A61K9/1617